Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 43.6M | 31.8M | 31.9M | 32.5M |
Selling general and admin | 15.4M | 14.4M | 14.8M | 15.5M |
Other operating expenses | — | — | — | — |
Operating income | -59.1M | -46.2M | -46.6M | -48.0M |
Non operating interest income | ||||
Income | 1.6M | 2.1M | 2.7M | 3.0M |
Expense | — | 0 | 0 | 0 |
Other income expense | 10K | -56K | -25K | -88K |
Pretax income | -57.5M | -44.1M | -43.9M | -45.1M |
Tax provision | — | — | — | — |
Net income | -57.5M | -44.1M | -43.9M | -45.1M |
Basic EPS | -1.1 | -0.8 | -0.8 | -0.9 |
Diluted EPS | -1.1 | -0.8 | -0.8 | -0.9 |
Basic average shares | 52.7M | 59.0M | 58.9M | 58.8M |
Diluted average shares | 52.7M | 59.0M | 58.9M | 58.8M |
EBITDA | -52.3M | -37.4M | -37.2M | -38.4M |
Net income from continuing op. | -57.5M | -44.1M | -43.9M | -45.1M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |